ArticleMicrobiology spectrum2025
Overview of botulinum neurotoxin-producing clostridia in soils in France.
Article in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Botulinum neurotoxin: from molecular pathogenesis to emerging countermeasures.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2026Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Soil is a known reservoir of human pathogens, including botulinum neurotoxin-producing clostridia. However, the occurrence and distribution of botulinum neurotoxin types in French soils are unknown, prompting this study. Botulinum neurotoxin-producing clostridia were sought, and botulinum neurotoxin types were identified through an analysis of 486 soil samples representative of nationwide soil type and land use, provided by the French Soil Quality Monitoring Network. Botulinum neurotoxin-producing clostridia were detected in 45.3% of soil samples, with type B-producing clostridia being the most frequently detected (40.1% of soil samples). Geographical variability was observed, with samples from the North of France being more frequently positive than those from the South. A comparison of these detection results with the characteristics of soils and climate conditions revealed three soil clusters. IMPORTANCE: Botulism is a flaccid paralysis disease caused by one of the seven neuroparalytic toxins produced by anaerobic spore-forming clostridia. While soil is reported in the literature as being an important reservoir of clostridia capable of producing botulinum neurotoxins, no study has been conducted in France up to now to establish its prevalence and study soil factors influencing its occurrence. The significance of our research is in providing a global picture of the unequal distribution of botulinum neurotoxin-producing clostridia and detected subtypes countrywide, showing that types involved in human botulism outbreaks are commonly detected, while those involved in animal outbreaks are rare. Finally, the stability of spores was evaluated. Results showed a high persistence of spores under tested conditions. This study provides new data regarding the distribution of botulinum neurotoxin-producing clostridia in soils that are crucial for a better understanding and management of animal and human botulism outbreaks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.